V. Mongiellová

Ciprofibrate Increases Plasma Concentration of Platelet-Derived Growth Factor AB in Patients with Advanced Atherosclerosis and Hyperlipidemia Independently of Its Hypolipidemic Effects

M. Gajdoš, Z. Krivošíková, V. Spustová, 2001, Journal of cardiovascular pharmacology.

Clinical Research Anti-cytomegalovirus antibodies and other atherosclerosis risk factors in patients with cardiovascular diseases

V. Fridrich, J. Tomka, M. Gajdoš, 2007 .

The importance of the presence of aggregatibacter actinomycetemcomitans in sulcus gingivalis of patients with cardiovascular diseases

L. Wsólová, M. Straka, J. Kazar, 2011, Medical science monitor : international medical journal of experimental and clinical research.

Relationship between plasma fenofibric acid levels and the effect of micronized fenofibrate on cholesterol, low-density-lipoprotein cholesterol and apolipoprotein B in patients with primary hypercholesterolemia

T. Trnovec, K. Rašlová, D. Dubovská, 1997, European Journal of Clinical Pharmacology.

Anti-cytomegalovirus antibodies and other atherosclerosis risk factors in patients with cardiovascular diseases

V. Fridrich, J. Tomka, M. Gajdoš, 2007 .

Serum ex vivo lipoprotein oxidizability in patients with ischemic heart disease supplemented with vitamin E.

A. Nagyová, M. Gajdoš, Z. Krivošíková, 2002, Physiological research.